Treatment recommendations for nail unit toxicities secondary to targeted cancer therapy based on collective experience and evidence-based literature review - 14/06/22
Doi : 10.1016/j.jaad.2021.07.022
Megan L. Wetzel, MD, MPH a, Adam I. Rubin, MD b, Hannah Hanania, BA c, Anisha B. Patel, MD d, ⁎ 
a Neighborhood Dermatology, Plano, Texas
b Department of Dermatology, Hospital of the University of Pennsylvania, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Pennsylvania
c Baylor College of Medicine, Houston, Texas
d Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas
∗Correspondence to: Anisha B. Patel, MD, Department of Dermatology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1452, Houston, TX 77030Department of DermatologyThe University of Texas MD Anderson Cancer Center1515 Holcombe Blvd, Unit 1452HoustonTX77030
| Funding sources: None. |
|
| IRB approval status: Approved with waiver of consent. |
|
| Reprints not available from the authors. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 87 - N° 1
P. 180-183 - juillet 2022 Retour au numéro
Article précédent
- Internet searches for Black dermatologists during the social justice movement of 2020
- Megan V. Ha, Rishabh S. Mazmudar, Bryan T. Carroll
- Exercise in dermatology: Exercise's influence on skin aging, skin cancer, psoriasis, venous ulcers, and androgenetic alopecia
- Christopher Yeh, Elizabeth Flatley, Omar Elkattawy, Lauren Berger, Babar Rao
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?